USP51 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.148410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.050600E-01
Normal-vs-Stage2
5.321500E-02
Normal-vs-Stage3
2.326400E-01
Normal-vs-Stage4
5.086200E-01
Stage1-vs-Stage2
2.275400E-01
Stage1-vs-Stage3
1.232760E-01
Stage1-vs-Stage4
5.988600E-01
Stage2-vs-Stage3
4.602200E-01
Stage2-vs-Stage4
3.752000E-01
Stage3-vs-Stage4
1.961440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.101360E-01
Normal-vs-AfricanAmerican
7.094800E-01
Normal-vs-Asian
6.483800E-02
Caucasian-vs-AfricanAmerican
1.913560E-01
Caucasian-vs-Asian
3.333200E-01
AfricanAmerican-vs-Asian
1.342030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.519900E-02
Normal-vs-Female
1.632630E-01
Male-vs-Female
3.185000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.702000E-01
Normal-vs-Age(41-60Yrs)
2.403200E-01
Normal-vs-Age(61-80Yrs)
8.504300E-02
Normal-vs-Age(81-100Yrs)
2.216800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.183800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.349900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.842800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.870360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.935100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.763400E-01
Normal-vs-Daily Drinker
2.496400E-01
Normal-vs-Weekly Drinker
2.922000E-01
Normal-vs-Occasional Drinker
1.110150E-01
Normal-vs-Social Drinker
6.777000E-01
Non Drinker-vs-Daily Drinker
5.787400E-01
Non Drinker-vs-Weekly Drinker
8.223400E-01
Non Drinker-vs-Occasional Drinker
2.806600E-01
Non Drinker-vs-Social Drinker
1.211380E-01
Daily Drinker-vs-Weekly Drinker
4.720200E-01
Daily Drinker-vs-Occasional Drinker
1.460000E-01
Daily Drinker-vs-Social Drinker
8.304100E-02
Weekly Drinker-vs-Occasional Drinker
4.650200E-01
Weekly Drinker-vs-Social Drinker
1.499040E-01
Occasional Drinker-vs-Social Drinker
3.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.405800E-01
Normal-vs-Grade 2
2.617800E-01
Normal-vs-Grade 3
2.329800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.952180E-01
Grade 1-vs-Grade 3
3.595600E-01
Grade 1-vs-Grade 4
2.405800E-01
Grade 2-vs-Grade 3
7.629400E-01
Grade 2-vs-Grade 4
2.617800E-01
Grade 3-vs-Grade 4
2.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.989000E-01
Normal-vs-NonDiabetic
1.059050E-01
Diabetic-vs-NonDiabetic
3.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.463200E-01
Normal-vs-NoPancreatitis
9.901800E-02
Pancreatitis-vs-NoPancreatitis
6.538000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.954760E-01
Normal-vs-N1
7.275600E-02
N0-vs-N1
8.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.865200E-01
Normal-vs-TP53-NonMutant
5.966400E-01
TP53-Mutant-vs-TP53-NonMutant
2.174400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
